Continuous intravenous infusion of enfuvirtide in a patient with a multidrug-resistant HIV strain.

about

Continuous intravenous infusion of enfuvirtide in a patient with a multidrug-resistant HIV strain.

Item

http://www.wikidata.org/entity/Q40674380

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Continuous intravenous infusio ...... ultidrug-resistant HIV strain.

@en

type

Item

label

Continuous intravenous infusio ...... ultidrug-resistant HIV strain.

@en

prefLabel

Continuous intravenous infusio ...... ultidrug-resistant HIV strain.

@en

P1476

Continuous intravenous infusio ...... ultidrug-resistant HIV strain.

@en

P2093

Andy I M Hoepelman

http://www.w3.org/2001/XMLSchema#string

Annemarie M J Wensing

http://www.w3.org/2001/XMLSchema#string

Antonio D'Avolio

http://www.w3.org/2001/XMLSchema#string

Erik M Van Maarseveen

http://www.w3.org/2001/XMLSchema#string

Robert W Neijzen

http://www.w3.org/2001/XMLSchema#string

Stefano Bonora

http://www.w3.org/2001/XMLSchema#string

Tania Mudrikova

http://www.w3.org/2001/XMLSchema#string

P2860

Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America

Efficacy and safety of raltegravir in treatment-experienced HIV-1-infected patients switching from enfuvirtide-based regimens: 48 week results of the randomized EASIER ANRS 138 trial.

Enfuvirtide: a review of its use in the management of HIV infection.

Mechanism-based model of the pharmacokinetics of enfuvirtide, an HIV fusion inhibitor.

Pharmacokinetics of plasma enfuvirtide after subcutaneous administration to patients with human immunodeficiency virus: Inverse Gaussian density absorption and 2-compartment disposition.

An improved HPLC fluorimetric method for the determination of enfuvirtide plasma levels in HIV-infected patients.

Pharmacokinetic and pharmacodynamic determinants of early virological response to enfuvirtide-based regimens in HIV-positive patients.

Efficacy of enfuvirtide in patients infected with drug-resistant HIV-1 in Europe and Australia.

P2888

s11096-016-0316-3

P304

749-751

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11096-016-0316-3

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-05-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27180258

http://www.w3.org/2001/XMLSchema#string

P921

multiple drug resistance